Challenges and progress in access to rare cancer drugs in China: Insights from clinical trials, availability and affordability.

Luo X, Du X, Xiao J, Liu X, Huang L, Zhang X

Open source

DOI
10.1016/j.drudis.2026.104810
Published
2026 Sep 23
Container
Drug discovery today
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2026.104810,
  title = {Challenges and progress in access to rare cancer drugs in China: Insights from clinical trials, availability and affordability.},
  author = {Luo X and Du X and Xiao J and Liu X and Huang L and Zhang X},
  year = {2026},
  journal = {Drug discovery today},
  doi = {10.1016/j.drudis.2026.104810},
  url = {https://doi.org/10.1016/j.drudis.2026.104810}
}

RIS

TY  - JOUR
TI  - Challenges and progress in access to rare cancer drugs in China: Insights from clinical trials, availability and affordability.
AU  - Luo X
AU  - Du X
AU  - Xiao J
AU  - Liu X
AU  - Huang L
AU  - Zhang X
PY  - 2026
JO  - Drug discovery today
DO  - 10.1016/j.drudis.2026.104810
UR  - https://doi.org/10.1016/j.drudis.2026.104810
ER  - 

APA

X, L., X, D., J, X., X, L., L, H., & X, Z. (2026). Challenges and progress in access to rare cancer drugs in China: Insights from clinical trials, availability and affordability.. Drug discovery today. https://doi.org/10.1016/j.drudis.2026.104810

Source records